These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9531043)

  • 1. Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment.
    Tripodi A; Cattaneo M; Molteni A; Cesana BM; Mannucci PM
    Thromb Haemost; 1998 Mar; 79(3):571-3. PubMed ID: 9531043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
    Bruhn HD; Zurborn KH
    Dtsch Med Wochenschr; 1993 Jul; 118(26):967-70. PubMed ID: 8519230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
    Bruhn HD; Zurborn KH
    J Heart Valve Dis; 1995 Mar; 4(2):138-40. PubMed ID: 8556173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
    Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
    Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
    Tientadakul P; Opartkiattikul N; Sangtawesin W; Sakiyalak P
    J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
    Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between total prothrombin, native prothrombin and the International Normalized Ratio (INR).
    Braun PJ; Szewczyk KM
    Thromb Haemost; 1992 Aug; 68(2):160-4. PubMed ID: 1412161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of periodontal treatment on oral anticoagulation in patients with heart disease.
    Moreira P; Filho PM; Silva EA; Weksler C; Drable SG; Tura BR; Fonseca Mda G; Cunha AB; Fischer RG
    Rev Port Cardiol; 2007 Oct; 26(10):977-89. PubMed ID: 18232621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The necessity to assess anticoagulation status in elderly injured patients.
    Williams TM; Sadjadi J; Harken AH; Victorino GP
    J Trauma; 2008 Oct; 65(4):772-6; discussion 776-7. PubMed ID: 18849789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring for oral anticoagulant therapy].
    Nakagawa K; Nakahara Y; Tsuji H
    Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.